Why A Bristol-Myers Squibb Bid On Celgene Is Plausible
April 24, 2015 at 13:31 PM EDT
Bristol-Myers Squibb Co (NYSE: BMY)'s rumored interest in acquiring Celgene Corp. (NASDAQ: CELG) sounds plausible, an analyst ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|